At ASMS 2025, SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation ...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

The focus will initially be on creating computational and digital pathology products, as well as AI-assisted algorithms.

Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An ...

We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at ...

Danaher Corporation, a key player in Life Sciences, Biotechnology, and Diagnostics, has shown mixed financial performance with recent declines in revenue and net earnings. Despite recent struggles ...

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments ...

Danaher Corporation incorporates science and technology and has a market cap of $150B. The company has mixed financials, with its gross profit margin being its strongest and most consistent.

The industry as a whole closed the day down 0.2%. By the end of trading, Danaher Corporation fell $1.02 (-1.6%) to $63.68 on average volume. Throughout the day, 3,164,346 shares of Danaher ...

About a year ago, Danaher Corporation's (NYSE: DHR) valuation looked cheap relative to its peers. Of course, when I write peers, I mean its medical, life sciences, and diagnostics peers because ...

Danaher Corporation (NYSE:DHR) Executive Vice President Julie Sawyer Montgomery highlighted the goal of increasing access to precision medicines so that no patients are left behind, while ...

Danaher Corporation was a leading decliner within the industrial industry, falling $2.65 (-4.7%) to $53.45 on heavy volume. Editor's Note: TheStreet ratings do not represent the views of TheStreet ...